PTEN and prostate cancer: Interestingly a recent systemic review and bioinformatic analysis of 32 articles concluded that MRI visible prostate cancer is characterized by genomic features that correlate with aggressive disease including PTEN loss, DNA damage repair, proliferative signaling and higher genomic classifier scores (including GPS).25